Advertisement

Thyroid

  • H. J. Paltiel
  • R. Larsen
  • S. T. Treves

Abstract

Thyroid scintigraphy plays an important role in the evaluation of the thyroid gland owing to the functional and anatomic information it simultaneously provides. Both iodine-123 (123I) and tech-netium-99m (99mTc) may be used for diagnostic evaluation of the pediatric thyroid gland. The major indications for thyroid scintigraphy in children include neck masses, hypothyroidism, and hyperthyroidism.35 Iodine-131 (131I) has limited application in pediatric thyroid scintigraphy owing to its high radiation absorbed dose. Iodine-131 is employed in the treatment of hyperthyroidism in patients who do not respond to medical therapy or who are not compliant or who refuse surgery. Iodine-131 is used in patients with metastatic papillary carcinoma of the thyroid for the measurement of radioiodine turnover in metastases prior to 131I therapy.

Keywords

Thyroid Cancer Thyroid Carcinoma Thyroid Gland Thyroid Nodule Total Thyroidectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Attie JN. Thyroid carcinoma in children and adolescents. In Lifshitz F (ed): Pediatric Endocrinology. New York: Marcel Dekker, 1990:513–525Google Scholar
  2. 2.
    Attie JN, Khafif RA. Preservation of parathyroid glands during total thyroidectomy: improved technique utilizing microsurgery. Am J Surg 1975; 130:339–404CrossRefGoogle Scholar
  3. 3.
    Balon HR, Fink-Bennett D, Stoffer SS. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid. J Nucl Med 1992;33: 1393–1395PubMedGoogle Scholar
  4. 4.
    Beierwaltes WH, Nishiyama RH, Thompson NW, Copp JE, Kubo A. Survival time and “cure” in papillary and follicular carcinoma with distant metastases: statistics following University of Michigan therapy. J Nucl Med 1982;23:561–568PubMedGoogle Scholar
  5. 5.
    Bleichrodt RP, Vermey A, Piers DA, de Langen ZG. Early and delayed thallium 201 imaging: diagnosis of patients with cold thyroid nodules. Cancer 1987; 60:2621–2623PubMedCrossRefGoogle Scholar
  6. 6.
    Brennan MF, Bloomer WD. Cancer of the endocrine system. In De Vita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott, 1982:971–973Google Scholar
  7. 7.
    Brincker H, Hansen HS, Andersen AP. Induction of leukemia by 131I treatment of thyroid carcinoma. Br J Cancer 1973;28:232–237PubMedCrossRefGoogle Scholar
  8. 8.
    Buckwalter JA, Thomas CG, Freeman JB. Is childhood thyroid cancer a lethal disease? Ann Surg 1975;181:632–638PubMedCrossRefGoogle Scholar
  9. 9.
    Cady B, Sedgwick CE, Meissner WA, et al. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 1976;184:541–552PubMedCrossRefGoogle Scholar
  10. 10.
    Corstens F, Huysmans D, Kloppenborg P. Thallium-201 scintigraphy of the suppressed thyroid: an alternative for iodine-123 scanning after TSH stimulation. J Nucl Med 1988;29:1360–1363PubMedGoogle Scholar
  11. 11.
    Eisenberg BL, Hensley SD. Thyroid cancer with coexistent Hashimoto’s thyroiditis: clinical assessment and management. Arch Surg 1989; 124: 1045–1047PubMedCrossRefGoogle Scholar
  12. 12.
    Emmertsen K. Medullary thyroid carcinoma and calcitonin. Dan Med Bull 1985;32:1–28PubMedGoogle Scholar
  13. 13.
    Favus MJ, Schneider AB, Stachura ME, et al. Thyroid cancer occurring as a late consequence of head-and-neck irradiation: evaluation of 1056 patients. N Engl J Med 1976;294:1019–1025PubMedCrossRefGoogle Scholar
  14. 14.
    Fisher DA, Burrow GN, Dussault JH, et al. Recommendations for screening programs for congenital hypothyroidism: committee of the American Thyroid Association. J Pediatr 1976;89:692–694CrossRefGoogle Scholar
  15. 15.
    Frankenthaler RA, Sellin RV, Cangir A, Goepfert H. Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am J Surg 1990;160:341–343PubMedCrossRefGoogle Scholar
  16. 16.
    Fuks Z, Glatstein E, Marsa GW, Bagshaw MA, Kaplan HS. Long-term effects of external radiation on the pituitary and thyroid glands. Cancer 1976; 37:1152–1161PubMedCrossRefGoogle Scholar
  17. 17.
    Gharib H, McConahey WM, Tiegs RD, et al. Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clin Proc 1992; 67:934–940PubMedCrossRefGoogle Scholar
  18. 18.
    Goepfert H, Dichtel WJ, Samaan NA. Thyroid cancer in children and teenagers. Arch Otolaryngol 1984; 110:72–75PubMedCrossRefGoogle Scholar
  19. 19.
    Hamburger JI, Miller JM, Garcia M, et al. Is thyroid imaging an overutilized diagnostic procedure? In Hamburger JG, Miller JM (eds): Controversies in Clinical Thyroidology. New York: Springer 1981:1–20CrossRefGoogle Scholar
  20. 20.
    Holm L-E, Blomgren H, Löwhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl JMed 1985;312:601–604CrossRefGoogle Scholar
  21. 21.
    Hopwood NJ, Carroll RG, Kenny FM, Foley TP Jr. Functioning thyroid masses in childhood and adolescence: clinical, surgical, and pathologic correlations. J Pediatr 1976;89:701–708Google Scholar
  22. 22.
    Hung W, Anderson KD, Chandra RS, et al. Solitary thyroid nodules in 71 children and adolescents. J Pediatr Surg 1992;27:1407–1409PubMedCrossRefGoogle Scholar
  23. 23.
    Kao CH, Lin WY, Wang SJ, Yeh SH. Visualization of suppressed thyroid tissue by Tc-99m MIBI. Clin Nucl Med 1991;16;812–814PubMedCrossRefGoogle Scholar
  24. 24.
    Kay C, Abrahams S, McClain P. The weight of normal thyroid glands in children. Arch Pathol 1966; 82:349–352PubMedGoogle Scholar
  25. 25.
    Kirkland RT, Kirkland JL, Rosenberg HS, et al. Solitary thyroid nodules in 30 children and report of a child with a thyroid abscess. Pediatrics 1973; 51:85–90PubMedGoogle Scholar
  26. 26.
    Kusic Z, Becker DV, Saenger EL, et al. Comparison of technetium-99m and iodine-123 imaging of thyroid nodules: correlation with pathologic findings. J Nucl Med 1990;31:393–399PubMedGoogle Scholar
  27. 27.
    Maxon HR, Saenger EL, Thomas SR, et al. Clinically important radiation-associated thyroid disease: a controlled study. JAMA 1980;244:1802–1805PubMedCrossRefGoogle Scholar
  28. 28.
    Maxon HR, Thomas SR, Hertzberg VS, et al. Relation between effective radiation dose and outcome of radioiodine therapy in thyroid cancer. N Engl JMed 1983;309:937–941CrossRefGoogle Scholar
  29. 29.
    Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 1977;56:171–196Google Scholar
  30. 30.
    Mochizuki Y, Mowafy R, Pasternack B. Weights of human thyroids in New York City. Health Phys 1963;9:1299–1301PubMedCrossRefGoogle Scholar
  31. 31.
    Mueller S, Guth-Tougelides B, Creutzig H. Imaging of malignant tumors with Tc-99m-MIBI SPECT [abstract]. J Nucl Med 1989;30:845Google Scholar
  32. 32.
    NCRP Report No. 37. Precautions in the management of patients who have received therapeutic amounts of radionuclides. Washington, DC: NCRP Publications, 1973:6–23Google Scholar
  33. 33.
    Ochi H, Sawa H, Fukuda T, et al. Thallium-201-chloride thyroid scintigraphy to evaluate benign and/or malignant nodules: usefulness of the delayed scan. Cancer 1982;50:236–240PubMedCrossRefGoogle Scholar
  34. 34.
    Ott RA, McCall AR, McHenry C, et al. The incidence of thyroid carcinoma in Hashimoto’s thyroiditis. Am Surg 1987;53:442–445PubMedGoogle Scholar
  35. 35.
    Paltiel HJ, Summerville DA, Treves ST. Iodine-123 scintigraphy in the evaluation of pediatric thyroid disorders: a ten year experience. Pediatr Radiol 1992;22:251–256PubMedCrossRefGoogle Scholar
  36. 36.
    Pankow BG, Michalak J, McGee MK. Adult human thyroid weight. Health Phys 1985;49:1097–1103PubMedCrossRefGoogle Scholar
  37. 37.
    Pincus RA, Reichlin S, Hempelmann LH. Thyroid abnormalities after radiation exposure in infancy. Ann Intern Med 1967;66:1154–1164PubMedGoogle Scholar
  38. 38.
    Pochin EE. The occurrence of leukaemia following radioiodine therapy. In Pitt-Rivers R (ed): Advances in Thyroid Research. New York: Pergamon Press, 1961;392–397Google Scholar
  39. 39.
    Rall JE, Alpers JB, Lewallen CG, et al. Radiation pneumonitis and fibrosis: a complication of radioiodine treatment of pulmonary metastases from cancer of the thyroid. J Clin Endocrinol 1957;17:1263–1276CrossRefGoogle Scholar
  40. 40.
    Rallison ML, Dobyns BM, Keating FR, Rall JE, Tyler FH. Thyroid nodularity in children. JAMA 1975;233:1069–1072PubMedCrossRefGoogle Scholar
  41. 41.
    Ramanathan P, Patel RB, Subrahmanyam N, et al. Visualization of suppressed thyroid tissue by tech-netium-99m-tertiary butyl isonitrile: an alternative to post-TSH stimulation scanning. J Nucl Med 1990;31:1163–1165PubMedGoogle Scholar
  42. 42.
    Reasner CA Jr, Reasner CA, Isley WL. Thyroid scanning in patients with suspected thyroid disease. Ann InternMed 1985;102:209–210Google Scholar
  43. 43.
    Ron E, Modan B, Preston D, et al. Thyroid neoplasia following low-dose radiation in childhood. Radiat Res 1989;120:516–531PubMedCrossRefGoogle Scholar
  44. 44.
    Saad MF, Ordonez NG, Rashid RK, et al. Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine (Baltimore) 1984;63:319–342Google Scholar
  45. 45.
    Safa AM, Schumacher OP. Follow-up of children treated with 1–131 [letter]. N Engl J Med 1976;294:54PubMedGoogle Scholar
  46. 46.
    Safa AM, Schumacher OP, Rodriguez-Antunez A. Long-term follow-up results in children and adolescents treated with radioactive iodine[131I] for hyperthyroidism. N Engl J Med 1975;292:167–171PubMedCrossRefGoogle Scholar
  47. 47.
    Samaan NA, Maheshwari YK, Nader S, et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 1983;56:1131–1138PubMedCrossRefGoogle Scholar
  48. 48.
    Samaan NA, Schultz PN, Hickey RC. Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy. J Clin Endocrinol Metab 1988;67:801–805PubMedCrossRefGoogle Scholar
  49. 49.
    Sampson RJ. Prevalance and significance of occult thyroid cancer. In DeGroot LJ (ed): Radiation-Associated Thyroid Carcinoma. Orlando, FL: Grune & Stratton, 1977:137–153Google Scholar
  50. 50.
    Sarkar SD, Beierwaltes WH, Gill SP, Cowley BJ. Subsequent fertility and birth histories of children and adolescents treated with 131–1 for thyroid cancer. J Nucl Med 1976;17:460–464PubMedGoogle Scholar
  51. 51.
    Schlumberger M, De Vathaire F, Travagli JP, et al. Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab 1987;65:1088–1094PubMedCrossRefGoogle Scholar
  52. 52.
    Scott MD, Crawford JD. Solitary thyroid nodules in childhood: is the incidence of thyroid carcinoma declining? Pediatrics 1976;58:521–525PubMedGoogle Scholar
  53. 53.
    Silverman SH, Nussbaum M, Rausen AR. Thyroid nodules in children: a ten year experience at one institution. Mt Sinai J Med 1979;46:460–463PubMedGoogle Scholar
  54. 54.
    Sisson JC. Applying the radioactive eraser: 1–131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected [editorial]. J Nucl Med 1983;24:743–745PubMedGoogle Scholar
  55. 55.
    Snyder J, Gorman C, Scanlon P. Thyroid remnant ablation: questionable pursuit of an ill-defined goal. J Nucl Med 1983;24:659–665PubMedGoogle Scholar
  56. 56.
    Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA 1990;263:1529–1532PubMedCrossRefGoogle Scholar
  57. 57.
    Szabo SM, Allen DB. Thyroiditis: differentiation of acute suppurative and subacute; case report and review of the literature. Clin Pediatr 1989; 28:171–174CrossRefGoogle Scholar
  58. 58.
    Tucker MA, Morris Jones PH, Boice JD Jr, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 1991;51: 2885–2888PubMedGoogle Scholar
  59. 59.
    Webster EW, Alpert NM, Brownell GL. Radiation doses in pediatric nuclear medicine and diagnostic x-ray procedures. In James AE, Wagner HN, Cooke RE (eds): Pediatric Nuclear Medicine. Philadelphia: Saunders, 1974:34–58Google Scholar
  60. 60.
    Wells SA Jr, Dilley WG, Farndon JA, Leight GS, Baylin SB. Early diagnosis and treatment of medullary thyroid carcinoma. Arch Intern Med 1985;145:1248–1252PubMedCrossRefGoogle Scholar
  61. 61.
    Winship T, Rosvall RV. Thyroid carcinoma in childhood: final report on a 20 year study. Clin Proc Child Hosp Natl Med Cent 1970;26:327–348Google Scholar
  62. 62.
    Wolfstein RS. Enigma of the “hyperfunctioning” thyroid carcinoma resolved [letter]? J Nucl Med 1978;19:441–442PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • H. J. Paltiel
  • R. Larsen
  • S. T. Treves

There are no affiliations available

Personalised recommendations